| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 08/22/2000 | US6107039 Assays using base protected table 1 |
| 08/17/2000 | WO2000047599A1 Novel nucleosides and oligonucleotide analogues |
| 08/17/2000 | WO2000047593A1 Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds |
| 08/16/2000 | EP1027365A2 Antitumour uridine analogues |
| 08/16/2000 | EP1027364A2 Pyrimidine derivatives for labeled binding partners |
| 08/16/2000 | EP1027363A2 Adenosine a1-receptor agonists |
| 08/16/2000 | EP1027359A2 Monocyclic l-nucleosides, analogs and uses thereof |
| 08/16/2000 | EP0934325A4 Tetraphosphonate bicyclic trisanhydrides |
| 08/16/2000 | EP0707481B1 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 08/16/2000 | CN1263533A New formulation |
| 08/16/2000 | CN1055477C Intermediate compound for synthesizing nucleoside derivative |
| 08/15/2000 | US6103707 Treatment of herpes simplex virus 1 (hsv-1), herpes simplex virus 2 (hsv-2), human cytomegalovirus (hcmv) and varicella-zoster virus |
| 08/15/2000 | US6103701 Method for enhancing hematopoiesis with acyl deoxyribonucleosides |
| 08/15/2000 | CA2202280C Sugar modified nucleosides and their use for synthesis of oligonucleotides |
| 08/10/2000 | WO2000004866A9 Preparation of thioarabinofuranosyl compounds and use thereof |
| 08/09/2000 | EP1025115A1 Novel nucleoside or nucleotide fluorescent conjugates, preparation method and uses |
| 08/09/2000 | CN1055293C Method for preparing beta-thymidine |
| 08/09/2000 | CN1055292C Anti-hyperplasia and anti-inflammatory pentose monosaccharide derivative and medicinal composition containing same |
| 08/03/2000 | WO2000044763A2 Compositions for treating inflammatory response |
| 08/03/2000 | WO2000029418A3 Inhibitors of glycosidases and glycosyltransferases |
| 08/03/2000 | CA2361614E Compositions for treating inflammatory response |
| 08/02/2000 | EP1023456A1 Analyte assay using particulate labels |
| 08/02/2000 | EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules |
| 08/02/2000 | EP1023308A1 Inhibitors of nucleoside metabolism |
| 08/02/2000 | EP1022951A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 08/01/2000 | US6096875 Nucleoside/nucleotide including base, rigid linker, spacer and member of linkage pair or label; for terminators and chain-extenders in sanger-type dna sequencing or polymerase chain reactions |
| 08/01/2000 | US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors |
| 08/01/2000 | CA2028117C Substance trehalostatin and process for the preparation thereof |
| 07/27/2000 | WO2000043547A1 Dna mobility modifier |
| 07/27/2000 | WO2000043013A1 Pharmaceutical compositions for alleviating discomfort |
| 07/27/2000 | WO2000042868A1 Infant formula |
| 07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
| 07/27/2000 | WO1999063994A9 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 07/27/2000 | CA2627837A1 Pharmaceutical compositions for alleviating discomfort |
| 07/26/2000 | EP1021457A1 Method for the site specific synthesis of novel 3-hydroxypyridin-4(1h)-ons derivatives from aminomonosaccharides or aminoitols, products obtained by this method and their applications |
| 07/26/2000 | EP1021388A1 Phosphorylation process and catalyst |
| 07/26/2000 | EP1021175A1 Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 07/26/2000 | EP0836612B1 Novel synthons for stereoselective oligonucleotide synthesis |
| 07/26/2000 | EP0755458A4 Electrogenerated chemiluminescence labels for analysis and/or referencing |
| 07/26/2000 | CN1261372A Natural antitumor or antiviral substances and use of the same |
| 07/26/2000 | CN1261371A Process for the preparation of a deoxyuridine derivative |
| 07/26/2000 | CN1261370A Method of producing tiazofurin and other C-nucleosides |
| 07/26/2000 | CN1261284A Use of a CD40 : CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 07/25/2000 | US6093807 7-deaza-7-iodo-2'-substituted purine with 2'-o-alkoxy alkyl group on sugar moiety; increased nuclease resistance and binding affinity; diagnostics; antisense agents |
| 07/25/2000 | US6093703 Pharmaceutical compositions, containing S-adenosyl-L-methionine salt, 5-methyl-tetrahydrofolic acid and 5-formyltetrahydrofolic acid |
| 07/25/2000 | US6093698 Polysubstituted benzimidazoles as antiviral agents |
| 07/25/2000 | US6093555 Amido and peptido modified enzymatic nucleic acid molecules |
| 07/20/2000 | WO2000042057A1 Protecting groups for carbohydrate synthesis |
| 07/20/2000 | WO2000042054A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | WO2000042047A1 4-phenoxymethyl-substituted milbemycins |
| 07/20/2000 | WO2000015203A3 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor |
| 07/20/2000 | WO2000013487A3 Plant fungus inhibiting compounds, process for their preparation, compositions containing them and their use in a method for combatting plant fungi |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/20/2000 | CA2359986A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors |
| 07/19/2000 | EP1019887A2 Fluorescent cyanine dyes |
| 07/19/2000 | EP1019453A1 Aromatic-substituted xanthene dyes |
| 07/19/2000 | EP1019427A1 N?6 -substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 07/19/2000 | EP1019426A1 Novel a 1? adenosine receptor agonists and antagonists |
| 07/19/2000 | EP1019425A1 Modified benzimidazole nucleosides as antiviral agents |
| 07/19/2000 | EP1019423A2 Method for producing a pentopyranosyl nucleoside |
| 07/19/2000 | EP1019365A1 Novel compositions for the delivery of negatively charged molecules |
| 07/19/2000 | CN1260173A Immuno inhibitort |
| 07/19/2000 | CN1054510C Stable solution of rebeccamycin analog and preparation thereof |
| 07/18/2000 | US6090937 Methods for producing nucleoside derivatives and intermediates therefor |
| 07/18/2000 | US6090932 Method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 07/18/2000 | US6090610 Macrolide compound 0406 |
| 07/18/2000 | US6090602 Inhibiting hybridization of a reverse-transcribing dna strand with an rna template by delivering 1'-adenyl-, 1'-cytodinyl-, 1'-guanyl-, 1'-thymidyl-, or 1'-uridinyl-l-rhamnose; analog is phorphorylated and incorporated into synthesized dna |
| 07/13/2000 | WO2000040605A2 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 07/13/2000 | WO2000040591A1 Protonated/acidified nucleic acids and methods of use |
| 07/13/2000 | WO2000040584A2 Process for preparing n6-substituted deaza-adenosine derivatives |
| 07/13/2000 | WO2000040251A1 Use of adenosine agonists in cancer therapy |
| 07/13/2000 | CA2358962A1 Process for preparing n6-substituted deaza-adenosine derivatives |
| 07/13/2000 | CA2358570A1 Protonated/acidified nucleic acids and methods of use |
| 07/13/2000 | CA2358119A1 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 07/13/2000 | CA2356447A1 Use of adenosine agonists in cancer therapy |
| 07/12/2000 | EP1017841A1 Chromatographic method for mutation detection using mutation site specifically acting enzymes |
| 07/12/2000 | EP1017823A2 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/12/2000 | EP1017704A2 Use of a pentopyranosyl nucleoside for producing an electronic component, and conjugates of said pentopyranosyl nucleoside |
| 07/12/2000 | EP1017703A2 Pentopyranosyl nucleoside, and production and use of the same |
| 07/12/2000 | EP0977763A4 Protected aminosugars |
| 07/12/2000 | EP0783910B1 Process for the vacuum distillation of crude petroleum, and a facility for carrying out the process |
| 07/12/2000 | EP0673947B1 Psicofuranose and psicopyranose derivatives |
| 07/11/2000 | US6087490 Dinucleotide and oligonucleotide analogues |
| 07/11/2000 | US6087482 Heteroatomic oligonucleoside linkages |
| 07/11/2000 | US6087132 Preparing deoxyribonucleotide; incubation of enzymatic polypeptide with nucleic acids, enzymatic polypeptide catalyzes the reduction of the ribosyl group of the nucleic acids to form deoxyribonucleic acid, recovering |
| 07/11/2000 | CA2208569C Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 07/06/2000 | WO2000039144A1 Process for the preparation of fluorinated derivatives of nucleosides or sugars |
| 07/06/2000 | WO2000039143A2 Antiviral nucleoside analogues |
| 07/06/2000 | WO2000039138A1 Selective solvent extraction for the purification of protected nucleosides |
| 07/06/2000 | WO2000004036A9 Photocleavable nucleoside base |
| 07/05/2000 | EP1016866A1 NOVEL COMPOUND 2-AMINO-3-[2-(a)-MANNOPYRANOSYL)INDOL-3-YL]PROPIONIC ACID, PROCESS FOR PREPARING THE SAME, AND METHOD FOR INSPECTING FUNCTION OF LIVING BODY WITH THE NOVEL COMPOUND |
| 07/05/2000 | EP1015629A1 Bioconjugation of oligonucleotides |
| 07/05/2000 | EP1015627A1 Method for detecting a target compound using a nucleic acid ligand |
| 07/05/2000 | EP1015472A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
| 07/05/2000 | EP1015469A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 07/05/2000 | CN1258677A Synthesis and anticancer activity of conjugated phospholipid |
| 07/05/2000 | CN1054132C Process of separating thymidine from mixture |
| 07/04/2000 | US6084102 Covalently linked oligonucleotide minor grove binder conjugates |
| 07/04/2000 | US6084081 Fluorine-containing derivative with improved metabolic stability; for antiinflammatory agents and selectin blockers |
| 07/04/2000 | US6083482 Can be used as oligonucleotide building blocks or as small molecule pharmaceutical ingredients |